These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17881501)

  • 21. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memo mediates ErbB2-driven cell motility.
    Marone R; Hess D; Dankort D; Muller WJ; Hynes NE; Badache A
    Nat Cell Biol; 2004 Jun; 6(6):515-22. PubMed ID: 15156151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of integrin and erbB subunits in breast cancer cell lines.
    Shimizu H; Koyama N; Asada M; Yoshimatsu K
    Int J Oncol; 2002 Nov; 21(5):1073-9. PubMed ID: 12370757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
    Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression.
    Wong LL; Chang CF; Koay ES; Zhang D
    Int J Oncol; 2009 May; 34(5):1291-301. PubMed ID: 19360341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
    Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
    Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DC electric fields direct breast cancer cell migration, induce EGFR polarization, and increase the intracellular level of calcium ions.
    Wu D; Ma X; Lin F
    Cell Biochem Biophys; 2013; 67(3):1115-25. PubMed ID: 23657921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells.
    Li Q; Ahmed S; Loeb JA
    Cancer Res; 2004 Oct; 64(19):7078-85. PubMed ID: 15466203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR family: structure physiology signalling and therapeutic targets.
    Burgess AW
    Growth Factors; 2008 Oct; 26(5):263-74. PubMed ID: 18800267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
    Emanuel SL; Hughes TV; Adams M; Rugg CA; Fuentes-Pesquera A; Connolly PJ; Pandey N; Moreno-Mazza S; Butler J; Borowski V; Middleton SA; Gruninger RH; Story JR; Napier C; Hollister B; Greenberger LM
    Mol Pharmacol; 2008 Feb; 73(2):338-48. PubMed ID: 17975007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis.
    Saadi W; Wang SJ; Lin F; Jeon NL
    Biomed Microdevices; 2006 Jun; 8(2):109-18. PubMed ID: 16688570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N; Pust S; Sandvig K
    Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the aging vasculature and Erb B-2 signaling in epidermal growth factor-dependent intravasion of breast carcinoma cells.
    Price DJ; Avraham S; Jiang S; Fu Y; Avraham HK
    Cancer; 2004 Jul; 101(1):198-205. PubMed ID: 15222007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
    Zuo Y; Shields SK; Chakraborty C
    Biochem Biophys Res Commun; 2006 Dec; 351(2):361-7. PubMed ID: 17064663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cdc42: an effector and regulator of ErbB1 as a strategic target in breast cancer therapy.
    Hirsch DS; Wu WJ
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):147-57. PubMed ID: 17288526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-cadherin engagement provides a dominant stop signal for the migration of MDA-MB-468 breast carcinoma cells.
    Potthoff S; Entschladen F; Niggemann B; Zaenker KS; Lang K
    Breast Cancer Res Treat; 2007 Nov; 105(3):287-95. PubMed ID: 17171299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis.
    Wang SJ; Saadi W; Lin F; Minh-Canh Nguyen C; Li Jeon N
    Exp Cell Res; 2004 Oct; 300(1):180-9. PubMed ID: 15383325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy.
    Eccles SA; Modjtahedi H; Box G; Court W; Sandle J; Dean CJ
    Invasion Metastasis; 1994-1995; 14(1-6):337-48. PubMed ID: 7657527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.